Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Enzon Pharmaceuticals Inc (ENZN)

Enzon Pharmaceuticals Inc (ENZN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 9,819
  • Shares Outstanding, K 74,220
  • Annual Sales, $ 0 K
  • Annual Income, $ 1,370 K
  • 60-Month Beta 0.51
  • Price/Sales 327.30
  • Price/Cash Flow N/A
  • Price/Book 3.40
Trade ENZN with:
  • Price/Earnings ttm 13.50
  • Earnings Per Share ttm 0.01
  • Most Recent Earnings $0.00 on 08/08/24
  • Next Earnings Date 08/19/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend 0.240 on 09/30/19
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.1120 +18.13%
on 09/13/24
0.1700 -22.18%
on 08/22/24
-0.0276 (-17.26%)
since 08/16/24
3-Month
0.1120 +18.13%
on 09/13/24
0.1955 -32.33%
on 06/26/24
-0.0177 (-11.80%)
since 06/18/24
52-Week
0.0600 +120.50%
on 04/01/24
0.2400 -44.87%
on 06/10/24
-0.0077 (-5.50%)
since 09/18/23

Most Recent Stories

More News
Enzon Pharmaceuticals, Inc. CEO Andrew Rackear to Retire; Richard L. Feinstein, Enzon’s CFO, to Assume Position of CEO and Remain CFO

CRANFORD, N.J., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Enzon Pharmaceuticals, Inc. (OTC:ENZN) announced today that Andrew Rackear has communicated to the Board his intent to retire from his role as the Company’s...

ENZN : 0.1323 (-2.00%)
Enzon Pharmaceuticals Announces Results of Rights Offering

Looking to Next Step – Acquisition Opportunities

ENZN : 0.1323 (-2.00%)

Business Summary

Enzon Pharmaceuticals, Inc. is a biotechnology company. It discovers, develops, and commercializes therapeutics to treat life-threatening diseases. The Company's marketed drug products include PegIntron (R) for chronic hepatitis C; Sylatron (R) for Melanoma; Macugen (R) for neovascular age-related macular...

See More

Key Turning Points

3rd Resistance Point 0.1323
2nd Resistance Point 0.1323
1st Resistance Point 0.1323
Last Price 0.1323
1st Support Level 0.1323
2nd Support Level 0.1323
3rd Support Level 0.1323

See More

52-Week High 0.2400
Fibonacci 61.8% 0.1712
Fibonacci 50% 0.1500
Last Price 0.1323
Fibonacci 38.2% 0.1288
52-Week Low 0.0600

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar